观点互动调研

对于超重/肥胖的 T2DM 患者，「控糖」和「减重」都是疾病管理中必不可少的环节。然而，鉴于超重/肥胖可引发多种并发症，危害更为广泛，对超重/肥胖的 T2DM 患者进行体重控制的关注度越来越高。超重/肥胖的 T2DM 患者的血糖和体重到底该如何管理，临床一直存在不同声音。对于该话题，本篇内容进行了深入的分析和探讨，以期为临床实践提供启发和思考。

正确答案：B

正确答案：C

审批编码：PP-LD-CN-2438

获批日期：2024 年 1 月 12 日

内容策划：陈静、shaye

内容审核：陈宝平

题图来源：视觉中国

参考文献（上下滑动查看）

[1] 尹航,梁爽,何华等.高血糖“代谢记忆”治疗策略的研究进展[J].药学进展,2018,42(08).

[2] Bianchi C, Del Prato S. Metabolic memory and individual treatment aims in type 2 diabetes--outcome-lessons learned from large clinical trials. Rev Diabet Stud. 2011 Fall;8(3):432-40.

[3] Paul SK, Klein K, Thorsted BL, et al. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2015, 14: 100.

[4]Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study[J]. BMJ, 2000, 321(7258): 405-412.

[5] Verma S, Hussain M E. Obesity and diabetes: an update[J]. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2017, 11(1): 73-79.

[6] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南（2020年版）[J]. 中华糖尿病杂志,2021,13(4):315-409.

[7] Steven S, Hollingsworth KG, AlMrabeh A, et al. Very lowcalorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders[J]. Diabetes Care, 2016, 39(5): 808815.

[8] Zhou X, Ji L, Ran X, et al. Prevalence of obesity and its influence on achievement of cardiometabolic therapeutic goals in Chinese type 2 diabetes patients: an analysis of the nationwide, cross-sectional 3B study[J]. PloS one, 2016, 11(1): e0144179.

[9] ElSayed NA, Aleppo G, Aroda VR, et al.American Diabetes Association. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S128–S139.

未经允许不得转载：澳鸟-全球资讯平台 » 超重/肥胖的 T2DM 患者，「控糖」的风头不该被「减重」抢走